DUBLIN--(BUSINESS WIRE)--The "Global Peptic Ulcer Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been added to ResearchAndMarkets.com's offering.
The global Peptic ulcer drugs market was valued at US$ 4.63 Billion in 2016, and is expected to reach US$ 5.92 Billion by 2025, expanding at a CAGR of 2.8% from 2017 to 2025.
In the base year 2016, North America dominated the peptic ulcer drugs market in terms of revenue and it is anticipated that it will show steady growth during forecast period. Peptic ulcer affects more than 6 million population in the United States annually. Factors such as large number of affected population, higher cost of treatment medication, improved diagnostic technique and upsurge in funding by the government agencies in healthcare system are driving the market growth in North America.
On the other hand, Asia Pacific will show highest growth rate during forecast period due to changing lifestyle, higher number of affected population, increasing rate of smoking and rising healthcare awareness would expected to drive growth of peptic ulcers drugs market globally.
Key Market Movements:
- Factors such as increase in number of target population, improved diagnostic techniques, easy availability of treatment medication, preferable use of peptic ulcer medication over surgery and over use of painkiller medications are driving the growth of peptic ulcer drugs market globally.
- Furthermore change in lifestyle such as stress, diet, increase in rate of smocking would assist growth of peptic ulcer drugs market.
- However, wide availability of generic medication, poor patient compliance to medication in some countries and adverse effects associated with the use of medication which would negatively impacting market growth of peptic ulcer drugs.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Peptic Ulcer Drugs Market Analysis
Chapter 4 Global Peptic Ulcer Drugs Market, by Drug Class
Chapter 5 Global Peptic Ulcer Drugs Market, By Geography
Chapter 6 Company Profiles
- Abbott Laboratories
- AstraZeneca plc.
- Cadila Healthcare Ltd.
- Daewoong Pharmaceuticals
- Eisai Co. Ltd.
- PharmaKing Co. Ltd.
- Taiho Pharmaceutical (A Otsuka Holdings)
- Takeda Pharmaceutical
- Yuhan Corporation
For more information about this report visit https://www.researchandmarkets.com/research/pcv6t5/global_peptic?w=4